Biatros Kft.
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Biatros Kft., the GP office is conducting research aimed at improving management of arterial hypertension. The trial evaluates a single-pill combination of telmisartan, amlodipine, and hydrochlorothiazide to achieve better 24‑hour blood pressure reduction and stability.
- Blood pressure control strategies
- Combination antihypertensive therapy
- Patient adherence to simplified regimens
With two clinical studies and one investigator, the site contributes valuable data on cardiovascular risk reduction for patients across Grade 1 to Grade 3 hypertension.
Nutritional and Metabolic Diseases
Research at the clinic explores innovative treatments for obesity with or without type 2 diabetes. Participants receive a combined injectable regimen of semaglutide and cagrilintide to assess enhanced weight loss outcomes alongside lifestyle modifications.
- Weight reduction efficacy
- Dual‑agonist therapy benefits
- Integration with diet and exercise programs
The two‑trial portfolio, managed by a single investigator, aims to identify superior strategies for metabolic health improvement in the Hungarian population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Novo Nordisk A/S1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Biatros Kft.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Telmisartan/Amlodipine and Telmisartan/Amlodipine/Hydrochlorothiazide on 24-Hour Blood Pressure Control in Arterial Hypertension Patients | KRKA tovarna zdravil d.d. Novo mesto | Phase I | Not Recruiting | May 2024 | Aug 2025 |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amlodipine | 1 | Unknown | 2024-05-06 | 2024-05-06 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.